Merck (MRK) Revenue (2009 - 2025)

Merck (MRK) has 17 years of Revenue data on file, last reported at $65.0 billion in FY2025.

• Revenue for Q1 2026 came in at $16.3 billion, up 4.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $65.8 billion (up 2.89% YoY), and the FY2025 annual result was $65.0 billion, up 1.31% from the prior year.
• Revenue advanced to $65.0 billion in FY2025 per MRK's latest filing, from $64.2 billion in the prior year.
• Over five years, Revenue peaked at $65.0 billion in FY2025 and troughed at $48.7 billion in FY2021.
• A 5-year average of $59.5 billion and a median of $60.1 billion in 2023 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2025: Revenue grew 21.72% in 2022, then increased 1.31% in 2025.
• A 5-year view of Revenue shows it stood at $48.7 billion in 2021, then increased by 21.72% to $59.3 billion in 2022, then grew by 1.4% to $60.1 billion in 2023, then rose by 6.74% to $64.2 billion in 2024, then gained by 1.31% to $65.0 billion in 2025.
• Business Quant data shows MRK's Revenue at $65.0 billion in FY2025, $64.2 billion in FY2024, and $60.1 billion in FY2023.